Tertiary hyperparathyroidism
Tertiary Hyperparathyroidism is a medical condition characterized by the excessive secretion of parathyroid hormone (PTH) from the parathyroid glands, even after the correction of the long-standing hypercalcemia that is typically associated with secondary hyperparathyroidism. This condition is most commonly seen in patients with chronic kidney disease who have undergone dialysis for a prolonged period.
Etiology[edit | edit source]
Tertiary hyperparathyroidism develops as a result of long-standing secondary hyperparathyroidism. The continuous stimulation of the parathyroid glands due to low calcium levels in secondary hyperparathyroidism can lead to nodular hyperplasia, a condition where the parathyroid glands enlarge and produce excessive amounts of PTH, even when the calcium levels return to normal.
Clinical Presentation[edit | edit source]
Patients with tertiary hyperparathyroidism may present with symptoms of hypercalcemia, such as polyuria, polydipsia, nephrolithiasis, bone pain, and fractures. Neurological symptoms such as depression, fatigue, and memory loss may also be present.
Diagnosis[edit | edit source]
The diagnosis of tertiary hyperparathyroidism is made based on the clinical history, physical examination, and laboratory findings. The hallmark of this condition is the presence of high levels of both PTH and calcium in the blood. Imaging studies such as ultrasound of the neck and scintigraphy can be used to identify the enlarged parathyroid glands.
Treatment[edit | edit source]
The primary treatment for tertiary hyperparathyroidism is parathyroidectomy, the surgical removal of the parathyroid glands. This procedure is usually performed when the patient has severe symptoms or when the hypercalcemia is not responsive to medical management. Following surgery, patients may require lifelong supplementation with calcium and vitamin D.
Prognosis[edit | edit source]
The prognosis for tertiary hyperparathyroidism is generally good with appropriate treatment. However, if left untreated, the condition can lead to serious complications such as osteoporosis, kidney stones, and cardiovascular disease.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD